Physician profile
Edward R Assi
NPI 1669472544
$58,986.80
in general payments reported to CMS, 2019-2025
39 companies · $7,803 in 2025
The $7,803 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,135 · 2021: $6,123 · 2022: $8,093 · 2023: $11K · 2024: $6,513 · 2025: $7,803.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Travel and Lodging: $8,164 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,393.34 |
| Travel and Lodging | $8,164.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26,060.88 | 2021-2025 | Micra, Corevalve Evolut R, Symplicity G3 |
| Janssen Pharmaceuticals, INC | $11,153.51 | 2019-2020 | |
| Medtronic Vascular, INC. | $4,040.13 | 2019-2020 | |
| Inari Medical, INC. | $4,018.18 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $2,926.67 | 2020-2025 | Versacross Access Solution, Watchman, General - Vascular Intervention |
| Abiomed | $2,413.83 | 2019-2025 | Impella |
| Abbott Laboratories | $1,611.70 | 2019-2023 | Ensite Precision, Cardiomems, Perclose Prostyle |
| Shockwave Medical, INC | $1,321.99 | 2022-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $572.42 | 2019-2024 | |
| Philips North America LLC | $484.45 | 2019-2025 | Lm Undivided |
| Penumbra, INC. | $453.28 | 2021-2025 | Ruby Coil |
| Edwards Lifesciences Corporation | $438.27 | 2019-2023 | |
| Heartflow, INC. | $420.95 | 2022-2025 | Ffrct |
| Stryker Corporation | $410.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Amgen INC. | $378.40 | 2019-2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Assi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.